Jerry Wang
Director Técnico/Científico/I+D en I-MAB .
Origen de la red de primer grado Jerry Wang.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
11
| Public Company | Pharmaceuticals: Major | 11 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Jerry Wang a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member Chief Executive Officer Sales & Marketing | |
| Fu Jen Catholic University | College/University | Undergraduate Degree Graduate Degree | |
| Nanjing University | College/University | Undergraduate Degree | |
| FAR EAST HORIZON LIMITED | Finance/Rental/Leasing | Corporate Officer/Principal | |
| Standard Chartered Business Consulting Beijing Co. Ltd. | Corporate Officer/Principal | ||
Themes Investment Management Ltd.
 Themes Investment Management Ltd. Investment ManagersFinance Themes Investment Management Ltd is a private equity firm founded in 2009. The firm is headquartered in Hong Kong. | Investment Managers | Corporate Officer/Principal | |
| C-Bridge Capital Investment Management Ltd. | Chief Executive Officer | ||
| ASCLETIS PHARMA INC. | Biotechnology | Director/Board Member | |
| Nanyang Technological University | College/University | Undergraduate Degree | |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Medical Specialties | Director/Board Member | |
CBC Group (Singapore) Pte. Ltd.
 CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group (Singapore) Pte. Ltd.(CBC Group) is a private equity firm founded in 2014 by Wei Fu. The firm is headquartered in Singapore with additional offices in New York, Hong Kong, Shanghai and Beijing and is wholly owned by CBC Group Investment Management Ltd. | Investment Managers | Chief Executive Officer | |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED | Information Technology Services | Director/Board Member | |
| YSB INC. | Packaged Software | Director/Board Member | |
Shanghai Innostar Biotechnology Co., Ltd.
 Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Director/Board Member | |
| Chinese Pharmaceutical Association | Director/Board Member | ||
| JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD | Biotechnology | Director/Board Member | |
| HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| Shenyang Pharmaceutical University | College/University | Doctorate Degree | |
| CBC Group Co., Ltd. | Chief Executive Officer | ||
| China Pharmaceutical University | College/University | Corporate Officer/Principal | |
| CHANGZHOU QIANHONG BIOPHARMA CO.,LTD | Pharmaceuticals: Major | Director/Board Member | |
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| CSPC PHARMACEUTICAL GROUP LTD. | Biotechnology | Director/Board Member | |
| Gt Healthcare Group | Founder | ||
Ally Bridge Group HK Ltd
 Ally Bridge Group HK Ltd Investment ManagersFinance Ally Bridge Group HK Ltd (Ally Bridge) is a private equity firm founded in 2011 by Frank Yu. The firm is headquartered in Hong Kong with additional office in the US. | Investment Managers | Corporate Officer/Principal | |
Morningside Group (Holdings) Ltd.
 Morningside Group (Holdings) Ltd. Investment ManagersFinance Part of Morningside Group Ltd., the company is based in Shanghai, China. The Chinese company is involved in venture capital and private equity. | Investment Managers | Director/Board Member | |
JAFCO Investment (Asia Pacific) Ltd.
 JAFCO Investment (Asia Pacific) Ltd. Investment ManagersFinance JAFCO Investment (Asia Pacific) Ltd. (JAFCO ASIA) is a venture capital subsidiary of JAFCO Group Co., Ltd. founded in 1990. The firm is headquartered in Singapore. | Investment Managers | Director/Board Member | |
| DEUTSCHE BANK AG | Investment Banks/Brokers | Corporate Officer/Principal | |
| Columbia Business School | College/University | Graduate Degree | |
| CELLULAR BIOMEDICINE GROUP, INC. | Biotechnology | Director/Board Member | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The Hong Kong Institute of Financial Analysts & Professional | Corporate Officer/Principal | ||
| EVEREST MEDICINES LIMITED | Pharmaceuticals: Major | Chairman | |
Rock Mobile Corp.
 Rock Mobile Corp. Commercial Printing/FormsCommercial Services Rock Mobile Corp. creates and distributes music-centric entertainment services. The firm is a provider of entertainment services via internet, mobile internet and other mobile devices. It offers integrating and producing entertainment contents (including music and games, etc), constructing digital entertainment cloud platform and spreading its productions and services via internet, mobile internet, operators and mobile devices. The company was founded by Sam Duann and Joshua Maa in September 2002 and is headquartered in Guangzhou, China. | Commercial Printing/Forms | Chief Executive Officer | |
| Everest Medicines (Singapore) Pte Ltd. | Director/Board Member | ||
| AERIE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| BEIGENE, LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Qilu Pharmaceutical Co., Ltd.
 Qilu Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Qilu Pharmaceutical Co., Ltd. manufactures and markets generic drugs. It offers services in the areas of oncology, infections, cerebrovascular and cardiovascular, psychological and neurological system, respiratory system and ophthalmological diseases. The company was founded in 1958 and is headquartered in Jinan, China. | Pharmaceuticals: Generic | Sales & Marketing | |
| BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Genuine Biotech Ltd.
 Genuine Biotech Ltd. BiotechnologyHealth Technology Genuine Biotech Ltd. engages in the development, manufacturing, and commercialization of innovative drugs for the treatment of viral, oncological, and cerebrovascular diseases. The company was founded in 2012 and is headquartered in Pingdingshan, China. | Biotechnology | Director/Board Member | |
| Center For Drug Evaluation of NMPA | Chief Tech/Sci/R&D Officer | ||
| SUZHOU ZELGEN BIOPHARMACEUTICALS CO.,LTD. | Pharmaceuticals: Major | Director/Board Member | |
| China Medical University | College/University | Undergraduate Degree | |
| REMEGEN CO., LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Tamkang | College/University | Doctorate Degree | |
| Providence University | College/University | Undergraduate Degree | |
| SINPHAR PHARMACEUTICAL CO.,LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SYNCORE BIOTECHNOLOGY CO.,LTD | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MYCENAX BIOTECH INC. | Biotechnology | Corporate Officer/Principal | |
| AMRYT PHARMA PLC | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
| China | 26 |
| Taiwán | 7 |
| Hong-Kong | 7 |
| Estados Unidos | 6 |
| Singapur | 5 |
Sectorial
| Health Technology | 22 |
| Consumer Services | 10 |
| Finance | 8 |
| Commercial Services | 4 |
| Technology Services | 3 |
Operativa
| Director/Board Member | 81 |
| Independent Dir/Board Member | 34 |
| Corporate Officer/Principal | 23 |
| Director of Finance/CFO | 10 |
| Undergraduate Degree | 10 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Chia Hung Yang | 32 |
| Wei Fu | 21 |
| Pamela Klein | 19 |
| Shuai Chen | 19 |
| Chun Kwok Au | 14 |
| Rong Shao | 12 |
| Rajkumar Kannan | 11 |
| Yun Han Lin | 7 |
| Ruyi He | 7 |
| Yi Fei Zhu | 5 |
- Bolsa de valores
- Insiders
- Jerry Wang
- Conexiones Empresas
